Asa Nordling
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A Long-Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc-Conjugated siRNAs.
Journal: Clinical and translational science
Published: November 14, 2025
The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model.
Journal: Hepatology communications
Published: November 10, 2023
Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model.
Journal: Scientific reports
Published: August 29, 2023
Mechanistic, Functional, and Clinical Aspects of Pro-inflammatory Cytokine Mediated Regulation of ADME Gene Expression in 3D Human Liver Spheroids.
Journal: Clinical pharmacology and therapeutics
Published: December 22, 2022
The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids.
Journal: Cells
Published: December 16, 2022
Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis.
Journal: Cells
Published: February 18, 2020
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes.
Journal: Clinical pharmacology and therapeutics
Published: February 04, 2020
CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinoma.
Journal: Pharmacogenomics
Published: October 08, 2019
Human hepatic 3D spheroids as a model for steatosis and insulin resistance.
Journal: Scientific reports
Published: July 04, 2018
Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation.
Journal: Hepatology (Baltimore, Md.)
Published: February 16, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
Journal: Scientific reports
Published: October 29, 2015
Last Updated: 09/26/2026